St. Johns Investment Management Company LLC Increases Stock Position in UnitedHealth Group Incorporated $UNH

St. Johns Investment Management Company LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 38.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,592 shares of the healthcare conglomerate’s stock after purchasing an additional 991 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,121,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Brighton Jones LLC lifted its position in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. GAMMA Investing LLC lifted its position in shares of UnitedHealth Group by 7.4% during the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock valued at $8,295,000 after acquiring an additional 1,089 shares during the period. Walkner Condon Financial Advisors LLC raised its position in shares of UnitedHealth Group by 4.2% during the 1st quarter. Walkner Condon Financial Advisors LLC now owns 890 shares of the healthcare conglomerate’s stock worth $466,000 after purchasing an additional 36 shares during the last quarter. Finally, Foundation Wealth Management LLC PA raised its position in shares of UnitedHealth Group by 6.9% during the 1st quarter. Foundation Wealth Management LLC PA now owns 1,765 shares of the healthcare conglomerate’s stock worth $925,000 after purchasing an additional 114 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Bank of America lifted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. The Goldman Sachs Group started coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target for the company. Finally, Morgan Stanley boosted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $385.13.

UnitedHealth Group Stock Up 0.3%

Shares of NYSE UNH opened at $365.47 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The firm has a fifty day moving average of $333.70 and a 200-day moving average of $341.28. The stock has a market capitalization of $331.00 billion, a PE ratio of 15.83, a P/E/G ratio of 2.36 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the prior year, the firm earned $6.80 earnings per share. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.